当期报告
Unicycive(UNCY)03-15 04:05
$Unicycive(UNCY)$ 8-K Current report, items 1.01, 3.02, 5.03, and 9.01 Accession Number: 0001213900-24-022600 Act: 34 Size: 701 KB 网页链接
简介:Unicycive Therapeutics, Inc.于2016年8月18日在特拉华州注册成立。该公司一直处于休眠状态,直到2017年7月开始评估许可使用的多种药物。他们是一家生物技术公司,致力于为未满足的医疗条件开发治疗方法。当前,他们的两个计划针对有可能提供医疗收益的肾脏疾病。随着公司的发展和团队的建立,他们打算专注于确定肾脏疾病内外的医疗状况。他们目前的开发计划着重于两种新型疗法的开发:UNI 218或Renazorb(用于治疗慢性肾脏病患者的高磷酸盐血症)和UNI 494(用于治疗急性肾脏损伤)。
今开:1.05 | 昨收:1.03 |
最高:1.06 | 最低:1.01 |
涨停价: | 跌停价: |
总市值:39110895 |
Unicycive(UNCY)03-15 04:05
$Unicycive(UNCY)$ 8-K Current report, items 1.01, 3.02, 5.03, and 9.01 Accession Number: 0001213900-24-022600 Act: 34 Size: 701 KB 网页链接
Unicycive(UNCY)02-22 05:15
$Unicycive(UNCY)$ 8-K Current report, item 8.01 Accession Number: 0001213900-24-015753 Act: 34 Size: 198 KB 网页链接
Unicycive(UNCY)04-18 04:35
$Unicycive(UNCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-033831 Size: 5 KB 网页链接
Unicycive(UNCY)03-21 05:15
$Unicycive(UNCY)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001213900-24-024422 Act: 33 Size: 11 KB 网页链接
Unicycive(UNCY)04-18 04:35
$Unicycive(UNCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-033833 Size: 5 KB 网页链接
Unicycive(UNCY)04-27 05:15
$Unicycive(UNCY)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001213900-24-036720 Act: 34 Size: 30 KB 网页链接
Unicycive(UNCY)05-09 04:15
$Unicycive(UNCY)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001213900-24-040855 Act: 34 Size: 25 KB 网页链接
Unicycive(UNCY)04-17 04:15
$Unicycive(UNCY)$ PRE 14A Other preliminary proxy statements Accession Number: 0001213900-24-033430 Act: 34 Size: 724 KB 网页链接
Unicycive(UNCY)05-14 04:15
$Unicycive(UNCY)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-24-042298 Act: 34 Size: 6 MB 网页链接
Unicycive(UNCY)03-29 18:05
$Unicycive(UNCY)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-24-027373 Act: 34 Size: 298 KB 网页链接
不入流资讯2023-06-30 16:50
$Ontrak(OTRK)$ Unicycive Therapeutics sheds 15% premarket after Co. provided regulatory update on Lanthanum Dioxycarbonate program #AI_Mover# AInvestPro查看全文
药时代2023-03-14 17:41
很少有像磷结合剂这样特别的药物类型。药物机理非常简单明了,疗效也大差不差,但却在患者的痛点上无从下手。谁能解决这个痛点,就有可能卷走这个细分市场数亿美元的份额。
前几天,一家在做磷结合剂的biotech就拿到了唯梧资本领投的1.3亿美元融资(3000万首付款,1亿美元里程碑付款),在一...查看全文
SeekingBiotech2022-07-23 23:18
#肾病专科# License in 。
近期,李氏大药厂引进Unicycive Therapeutics主要候选药物Renazorb,一种正在开发以用于治疗高磷血症的新型磷酸盐结合剂。网页链接。
个人认为,李氏比一些资本攒局的公司好太多,毕竟还是踏实做产品的。有灵魂的制药企业。
高磷血症是几乎所有终末...查看全文
chuminhua2022-07-19 14:02
#授权in# 7月19日,Uncycive Therapeutics, Inc.(纳斯达克股票代码:UNCY)是一家为肾病患者开发疗法的临床阶段生物技术公司,今天宣布该公司已签署一项协议,授予Lee's Pharmaceutical (HK) Limited,Lee's Pharmaceutical Holdings Limited(“Lee's Pharm”)(联交所代码:950)...查看全文
鲜克有终72021-08-18 21:32
$Unicycive(UNCY)$ 学习大神标记看看查看全文
做空美股的王者2021-08-16 18:26
$Unicycive(UNCY)$ 财报快讯!查看全文
MAIKEZHE2021-08-04 02:39
$Unicycive(UNCY)$ 好好市场被倭寇病毒拖累查看全文
Truer2021-07-13 23:38
$Unicycive(UNCY)$ 开盘8.55 果断买入查看全文
7X24快讯2021-07-13 22:49
肾脏疾病生物技术公司Unicycive Therapeutics(UNCY.O)首日上市开涨54%,报7.7美元,IPO定价为5美元/股。查看全文
$Unicycive(UNCY)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-24-042338 Act: 34 Size: 275 KB 网页链接
$Unicycive(UNCY)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-24-042298 Act: 34 Size: 6 MB 网页链接
$Unicycive(UNCY)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001213900-24-040855 Act: 34 Size: 25 KB 网页链接
$Unicycive(UNCY)$ DEF 14A Other definitive proxy statements Accession Number: 0001213900-24-036716 Act: 34 Size: 769 KB 网页链接
$Unicycive(UNCY)$ ARS Annual Report to Security Holders Accession Number: 0001213900-24-036718 Act: 34 Size: 1 MB 网页链接
$Unicycive(UNCY)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001213900-24-036720 Act: 34 Size: 30 KB 网页链接
$Unicycive(UNCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-033828 Size: 5 KB 网页链接
$Unicycive(UNCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-033829 Size: 5 KB 网页链接
$Unicycive(UNCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-033831 Size: 5 KB 网页链接
$Unicycive(UNCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-033833 Size: 5 KB 网页链接